RARE financials

Ultragenyx (RARE) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.

RARE income statement, yearly

YearRevenueGross profitOperating incomeNet incomeEPS
2025$673.00M–-$535.00M-$575.00M-5.83
2024$560.00M–-$536.00M-$569.00M-6.29
2023$434.00M–-$569.00M-$607.00M-8.25
2022$363.33M–-$648.92M-$707.42M-10.12
2021$351.41M–-$381.74M-$454.02M-6.70
2020$271.03M–-$330.12M-$186.57M-3.07

Updated 2026-11-14 00:11 UTC